Ubicom to Acquire Radianceware in Push Toward Direct Medical IT Sales

Ubicom Holdings. Inc. ( (JP:3937) ) has shared an update.

Ubicom Holdings will acquire 100% of Radianceware Inc., a medical IT company with strong relationships among medical institutions in Saitama, the greater Tokyo area, and northern Kanto, and make it a subsidiary as part of its 2025–2030 strategic M&A program. The deal supports Ubicom’s shift from an agency-based model to a group direct sales structure, aiming to consolidate eight to ten regional sales firms to expand channels, strengthen its customer base and increase recurring revenue in its medical business.

Radianceware brings a proven implementation record, including top recognition for WebORCA claim processing systems, and deep expertise built through joint R&D with leading universities and participation in national healthcare DX initiatives, including medical data integration and AI-assisted rehabilitation. By combining Ubicom’s AI-driven Mighty solutions with Radianceware’s nearly 30-year sales infrastructure, the group plans cross-selling, product upgrades and higher transaction values per facility, reinforcing its position in Japan’s expanding medical DX market while funding the acquisition from internal resources.

The most recent analyst rating on (JP:3937) stock is a Hold with a Yen1206.00 price target. To see the full list of analyst forecasts on Ubicom Holdings. Inc. stock, see the JP:3937 Stock Forecast page.

More about Ubicom Holdings. Inc.

Ubicom Holdings, Inc. operates in the medical IT sector, providing AI-powered healthcare management support solutions under its “Mighty” series and historically selling mainly through regional sales agents. The group focuses on digital transformation for medical institutions across Japan, targeting clinics and small to mid-sized hospitals through a growing nationwide network of specialized medical IT distributors.

Average Trading Volume: 50,952

Technical Sentiment Signal: Strong Sell

Current Market Cap: Yen11.88B

For detailed information about 3937 stock, go to TipRanks’ Stock Analysis page.